Several other analysts have also recently commented on the stock. Analysts at Wunderlich Securities reiterated a “sell” rating on shares of Cree in a research note to investors on Wednesday. Separately, analysts at Canaccord Genuity reiterated a “buy” rating on shares of Cree in a research note to investors on Tuesday. Finally, analysts at Susquehanna initiated coverage on shares of Cree in a research note to investors on Friday, May 18th. They set a “positive” rating on the stock.
Cree traded up 0.04% on Thursday, hitting $25.92. Cree has a 1-year low of $20.25 and a 1-year high of $33.45. The company has a market cap of $2.997 billion and a price-to-earnings ratio of 54.21.
Cree last released its earnings data on Tuesday, April 17th. The company reported $0.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.21 by $0.01. The company’s revenue for the quarter was up 29.9% on a year-over-year basis. Analysts expect that Cree will post $0.28 EPS next quarter.
Cree, Inc. (Cree) develops and manufactures semiconductor materials and devices primarily based on silicon carbide (SiC), gallium nitride (GaN) and related compounds.